Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases
J Crohns Colitis
.
2022 Jul 14;16(6):1010.
doi: 10.1093/ecco-jcc/jjab107.
Authors
Marina Coletta
1
,
Moira Paroni
2
3
,
Maria Francesca Alvisi
4
,
Matilde De Luca
4
,
Eliana Rulli
4
,
Stefano Mazza
1
,
Federica Facciotti
5
,
Georgia Lattanzi
5
,
Francesco Strati
5
,
Sergio Abrignani
2
6
,
Massimo Claudio Fantini
7
,
Maurizio Vecchi
1
8
,
Jens Geginat
2
,
Flavio Caprioli
8
Affiliations
1
Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
2
Istituto Nazionale di Genetica Molecolare 'Enrica ed Romeo Invernizzi' [INGM], Milan, Italy.
3
Department of Biosciences, Università degli Studi di Milano, Milan, Italy.
4
Oncology Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
5
Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
6
Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
7
Department of Systems Medicine, Università di Roma Tor Vergata, Rome, Italy.
8
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
PMID:
34850867
DOI:
10.1093/ecco-jcc/jjab107
No abstract available
Publication types
Published Erratum